These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18930937)

  • 1. Commentary on "the impact of embolic protection device and stent design on the outcome of CAS".
    Wholey MH
    Perspect Vasc Surg Endovasc Ther; 2008 Sep; 20(3):280-1. PubMed ID: 18930937
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of embolic protection device and stent design on the outcome of CAS.
    Bosiers M; Deloose K; Verbist J; Peeters P
    Perspect Vasc Surg Endovasc Ther; 2008 Sep; 20(3):272-9. PubMed ID: 18930936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embolic protection devices for carotid artery stenting: have they made a significant difference in outcomes?
    Atkins MD; Bush RL
    Semin Vasc Surg; 2007 Dec; 20(4):244-51. PubMed ID: 18082841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary on "embolization during carotid angioplasty and stenting: what is the optimal method for detecting embolic debris and its sequelae?".
    Bassiouny H
    Perspect Vasc Surg Endovasc Ther; 2008 Sep; 20(3):270-1. PubMed ID: 18930935
    [No Abstract]   [Full Text] [Related]  

  • 5. Does carotid stent design influence outcomes?
    Bersin RM
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):863-6. PubMed ID: 19006255
    [No Abstract]   [Full Text] [Related]  

  • 6. Commentary on "flow reversal for cerebral protection in carotid artery stenting: a review".
    Parodi J
    Perspect Vasc Surg Endovasc Ther; 2008 Sep; 20(3):291-2. PubMed ID: 18930939
    [No Abstract]   [Full Text] [Related]  

  • 7. Flow reversal for cerebral protection in carotid artery stenting: a review.
    Kelso R; Clair DG
    Perspect Vasc Surg Endovasc Ther; 2008 Sep; 20(3):282-90. PubMed ID: 18930938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embolization during carotid angioplasty and stenting : what is the optimal method for detecting embolic debris and its sequelae?
    DeRubertis BG
    Perspect Vasc Surg Endovasc Ther; 2008 Sep; 20(3):260-9. PubMed ID: 18930934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distal filtration versus flow reversal: An ex vivo assessment of the choices for carotid embolic protection.
    Rapp JH; Zhu L; Hollenbeck K; Sarkar R; Velez PM; Reilly LM; Hiramoto J; Pan XM
    J Vasc Surg; 2009 May; 49(5):1181-8. PubMed ID: 19233591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary on "current indications for carotid angioplasty and stenting".
    Lumsden AB; Davies M
    Perspect Vasc Surg Endovasc Ther; 2008 Sep; 20(3):245-6. PubMed ID: 18930931
    [No Abstract]   [Full Text] [Related]  

  • 11. What practical factors guide the choice of stent and protection device during carotid angioplasty?
    Bosiers M; Deloose K; Verbist J; Peeters P
    Eur J Vasc Endovasc Surg; 2008 Jun; 35(6):637-43. PubMed ID: 18375153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carotid artery stenting using proximal balloon occlusion embolic protection.
    Keldahl ML; Phade SV; Eskandari MK
    Perspect Vasc Surg Endovasc Ther; 2010 Sep; 22(3):187-93. PubMed ID: 21098500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary on "The role of embolic protection devices in renal artery stenting".
    Corriere MA; Hansen KJ
    Perspect Vasc Surg Endovasc Ther; 2007 Sep; 19(3):272-4. PubMed ID: 17911554
    [No Abstract]   [Full Text] [Related]  

  • 14. The CABARNET trial more evidence...but what's next?
    Moussa ID
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):961-2. PubMed ID: 18500701
    [No Abstract]   [Full Text] [Related]  

  • 15. Is carotid stenting justified in the asymptomatic patient? Perspectives on indications for CAS.
    Wholey MH; Barbato JE
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):1081-3. PubMed ID: 17492784
    [No Abstract]   [Full Text] [Related]  

  • 16. Do we still need distal protection in the treatment of SVG disease?
    Satler LF
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):804-5. PubMed ID: 19009627
    [No Abstract]   [Full Text] [Related]  

  • 17. Commentary on "a review of the trials comparing carotid endarterectomy and carotid angioplasty and stenting".
    Oderich GS
    Perspect Vasc Surg Endovasc Ther; 2008 Sep; 20(3):309-10. PubMed ID: 18930942
    [No Abstract]   [Full Text] [Related]  

  • 18. Appropriate patient and device selection crucial for clinical benefit following renal stenting.
    Zeller T
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):24-5. PubMed ID: 20578189
    [No Abstract]   [Full Text] [Related]  

  • 19. Carotid stenting with embolic protection: evolutionary advances.
    Ansel GM; Jaff MR
    Expert Rev Med Devices; 2008 Jul; 5(4):427-36. PubMed ID: 18573043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond embolic protection for saphenous vein graft disease.
    Satler LF
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):641-2. PubMed ID: 18949778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.